Investing.com - Laboratory America reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Laboratory America announced earnings per share of $8.41 on revenue of $3.90B. Analysts polled by Investing.com anticipated EPS of $5.25 on revenue of $3.63B.
Laboratory America shares are up 19% from the beginning of the year and are trading at $201.96 , down-from-52-week-high.They are outperforming the S&P 500 which is up 5.27% from the start of the year.
Laboratory America follows other major Healthcare sector earnings this month
Laboratory America's report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.69 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar